Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
The Merck & Co. consumer brands in play in the company’s global creative review are Dr. Scholl’s, Miralax and an incontinence drug for women that’s shifting from prescription to over-the-counter sales.
The company’s initial request for proposals doesn’t name the incontinence drug. Collective media spending on the business in review is estimated at $50 million.
Merck is seeking a second global agency to work along side Euro RSCG on its non-prescription consumer brands. The Miralax and female incontinence drug assignments are global and the Dr.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in